Angela Klain, C. Indolfi, G. Dinardo, M. Contieri, F. Decimo, M. Miraglia Del Giudice
{"title":"Pathological Lung Ultrasound may Take Time to Resolve Despite Respiratory Symptoms Improvement: A Pediatric Case Series Followed for Long COVID","authors":"Angela Klain, C. Indolfi, G. Dinardo, M. Contieri, F. Decimo, M. Miraglia Del Giudice","doi":"10.2174/1573398x19666230619100036","DOIUrl":null,"url":null,"abstract":"\n\nLong COVID affects 8 to 10 % of children. Currently, the COVID-19 follow-up protocols in children include chest auscultation, collection of growth parameters, including weight, height and body mass index, execution of the six-minute walking test, basal spirometry, and afterwards, bronchodilation test and lung ultrasound.\n\n\n\nIn this paper, the authors describe a case series of long COVID followed up for 9 months at the Department of Pediatrics of the University Luigi Vanvitelli. The review of the literature was performed on PubMed using the keywords COVID-19, follow-up, children, and lung ultrasound. The aim of this article was to highlight the need to create custom follow-up programs for long Covid in children through the description of a case followed up at our Pediatric Department and a review of the current literature\n\n\n\nThe reversal of pathological lung ultrasound signs occurred in six or nine months despite the early improvement of respiratory symptoms and pulmonary function. There are limited studies on the ultrasonography follow-up of kids with COVID-19 in the literature, and there are still no follow-up COVID-19 guidelines for paediatric population.\n\n\n\nPathological lung ultrasound in children recovered from COVID-19, may take time to resolve; therefore, evaluating patients with lung ultrasound in the following months could be a radiation-saving approach useful for children who have fully recovered and have no warning signs.\n","PeriodicalId":44030,"journal":{"name":"Current Respiratory Medicine Reviews","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2023-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Respiratory Medicine Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573398x19666230619100036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
Long COVID affects 8 to 10 % of children. Currently, the COVID-19 follow-up protocols in children include chest auscultation, collection of growth parameters, including weight, height and body mass index, execution of the six-minute walking test, basal spirometry, and afterwards, bronchodilation test and lung ultrasound.
In this paper, the authors describe a case series of long COVID followed up for 9 months at the Department of Pediatrics of the University Luigi Vanvitelli. The review of the literature was performed on PubMed using the keywords COVID-19, follow-up, children, and lung ultrasound. The aim of this article was to highlight the need to create custom follow-up programs for long Covid in children through the description of a case followed up at our Pediatric Department and a review of the current literature
The reversal of pathological lung ultrasound signs occurred in six or nine months despite the early improvement of respiratory symptoms and pulmonary function. There are limited studies on the ultrasonography follow-up of kids with COVID-19 in the literature, and there are still no follow-up COVID-19 guidelines for paediatric population.
Pathological lung ultrasound in children recovered from COVID-19, may take time to resolve; therefore, evaluating patients with lung ultrasound in the following months could be a radiation-saving approach useful for children who have fully recovered and have no warning signs.
期刊介绍:
Current Respiratory Medicine Reviews publishes frontier reviews on all the latest advances on respiratory diseases and its related areas e.g. pharmacology, pathogenesis, clinical care, and therapy. The journal"s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in respiratory medicine.